The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 05, 2018

Filed:

Mar. 21, 2013
Applicant:

Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, AU;

Inventors:

Mireille Hanna Lahoud, East Melbourne, AU;

Anna Irene Proietto, Bulleen, AU;

Irina Caminschi, Ascot Vale, AU;

Ken Shortman, Princess Hill, AU;

Andrew Mark Lew, Essendon, AU;

Li Wu, Ascot Vale, AU;

Mark Dexter Wright, Northcote, AU;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/00 (2006.01); C07K 14/00 (2006.01); C07K 17/00 (2006.01); C07K 14/705 (2006.01); A61K 39/385 (2006.01); A61K 47/48 (2006.01); A61K 51/10 (2006.01); C07K 16/18 (2006.01); C12N 15/82 (2006.01); G01N 33/50 (2006.01); A61K 39/39 (2006.01); A61K 39/00 (2006.01); G06F 19/16 (2011.01);
U.S. Cl.
CPC ...
C07K 14/705 (2013.01); A61K 39/385 (2013.01); A61K 39/39 (2013.01); A61K 47/48561 (2013.01); A61K 51/1027 (2013.01); C07K 14/7056 (2013.01); C07K 16/18 (2013.01); C12N 15/8258 (2013.01); G01N 33/5005 (2013.01); G01N 33/5047 (2013.01); A61K 2039/6056 (2013.01); C07K 2317/73 (2013.01); G01N 2333/42 (2013.01); G01N 2333/4724 (2013.01); G06F 19/16 (2013.01);
Abstract

The present invention relates to the identification of proteins located on the cell surface of dendritic cells or precursors thereof, particularly antigen presenting dendritic cells. In particular, the present invention relates to compounds such as antibodies that bind these proteins. These compounds can be used to detect and/or enrich a subset of dendritic cells or precursors thereof. These compounds can also be used to target antigens to dendritic cells or precursors thereof to modulate a humoral and/or T cell mediated immune response to an antigen, or used to target cytotoxic agents to dendritic cells or precursors thereof involved in diseased states.


Find Patent Forward Citations

Loading…